Signals 06: April 2026

Acquisitions, Ecosystems, Platforms, Pivots

Happy Friday! Welcome back to Signals, a members-only newsletter analyzing key commercial developments across the neurotech industry each month.

This edition covers top developments from April 2026, which produced a flurry of commercial milestones across implanted BCI and non-invasive neuromodulation that reveal how markets are evolving:

• Motif and MintNeuro Partner on BCI Chip Layer

• Epia Neuro Emerges as Stroke BCI Moves Toward Recovery

• Neurable Turns Consumer EEG Into an OEM Layer

• Axoft’s $55m Series A brings BCI closer to Biotech

• Will Noctrix’ Acquisition Drive New Interest in Wearable Neuromod?

• Bioness Medical Acquires the Portable Neuromodulation Stimulator (PoNS System

• NeurAxis Expands Payer Coverage with Four New Medical Policies

Let’s dive in.

(And don’t forget, if you are allergic to paying for neurotech analysis, you can still unlock free access by sharing this newsletter with your network!)